Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS: ELOX · Delayed Price · USD
0.730
+0.030 (4.29%)
Jul 2, 2024, 11:06 AM EDT - Market closed
Eloxx Pharmaceuticals Market Cap
Eloxx Pharmaceuticals has a market cap or net worth of $2.29 million as of July 2, 2024. Its market cap has decreased by -87.39% in one year.
Market Cap
2.29M
Enterprise Value
3.28M
1-Year Change
-87.39%
Ranking
n/a
Category
Stock Price
$0.73
Market Cap Chart
Since April 26, 1999, Eloxx Pharmaceuticals's market cap has decreased from $16.70M to $2.29M, a decrease of -86.26%. That is a compound annual growth rate of -7.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 13, 2023 | 10.50M | 169.23% |
Dec 30, 2022 | 3.90M | -93.60% |
Dec 31, 2021 | 60.90M | -61.89% |
Dec 31, 2020 | 159.80M | -45.72% |
Dec 31, 2019 | 294.40M | -30.20% |
Dec 31, 2018 | 421.80M | 1,947.57% |
Dec 29, 2017 | 20.60M | 610.34% |
Dec 30, 2016 | 2.90M | -64.63% |
Dec 31, 2015 | 8.20M | -28.07% |
Dec 31, 2014 | 11.40M | -40.00% |
Dec 31, 2013 | 19.00M | 1.60% |
Dec 31, 2012 | 18.70M | -10.95% |
Dec 30, 2011 | 21.00M | 10.53% |
Dec 31, 2010 | 19.00M | 126.19% |
Dec 31, 2009 | 8.40M | -49.70% |
Dec 31, 2008 | 16.70M | 32.54% |
Dec 31, 2007 | 12.60M | -34.38% |
Dec 29, 2006 | 19.20M | -12.33% |
Dec 30, 2005 | 21.90M | -54.56% |
Dec 31, 2004 | 48.20M | 22.03% |
Dec 31, 2003 | 39.50M | 58.00% |
Dec 31, 2002 | 25.00M | 39.66% |
Dec 31, 2001 | 17.90M | 17.76% |
Dec 29, 2000 | 15.20M | -27.96% |
Dec 31, 1999 | 21.10M | 26.35% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 869.02B |
Novo Nordisk | 643.34B |
UnitedHealth Group | 455.27B |
Johnson & Johnson | 352.43B |
Merck & Co. | 323.95B |
AbbVie | 300.85B |
AstraZeneca | 241.65B |
Novartis AG | 208.44B |